Trading Signals: EDIT Stock Price Prediction and Forecast (Wed. Feb. 3, 2016 - Fri. Dec. 22, 2023)(EDITAS MEDICIN)
| EDIT latest price $60.8300 (-3.34%) ($60.8300 - $64.0400) on Tue. Sep. 14, 2021. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 5.62% (three month average) | RSI | 47 | Latest Price | $60.8300(-3.34%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | EDIT declines -1.8% a day on average for past five trading days. | Weekly Trend | EDIT declines -0.7% a week on average for past two weeks. | Market Behavior | Value stocks sell-off for large cap. Broad based sell-off for small cap. | Correlated ETFs | Broad market will support EDIT advance at 0% a week (0% probability) IBB(69%) IWO(63%) IBUY(62%) IWC(61%) IWM(59%) | Factors Impacting EDIT price | EDIT will decline at least -2.81% in a week (0% probabilities). VIXM(-33%) UUP(-16%) VXX(-12%) TBT(-7%) IGOV(-2%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -2.81% (StdDev 5.62%) | Hourly BBV | -2.1 () | Intraday Trend | 0% | | | |
|
Resistance Level | $64.24 | 5 Day Moving Average | $63.75(-4.58%) | 10 Day Moving Average | $65.58(-7.24%) | 20 Day Moving Average | $64.24(-5.31%) | To recent high | -16.5% | To recent low | 74.1% | Market Cap | $3.778b | | | | Editas Medicine, Inc. engages in the development and commercialization of genome editing technology. Its technology includes clustered, regularly interspaced short palindromic repeats (CRISPR), and CRISPR associated protein 9 (Cas9). The company was founded by Feng Zhang, Jennifer A. Doudna, George McDonald Church, J. Keith Joung and David R. Liu in September 2013 and is headquartered in Cambridge, MA. |